Daniel S. Chao
Corporate Officer/Principal at RubrYc Therapeutics, Inc.
Profile
Daniel S.
Chao was the founder of Halo Neuro, Inc. (founded in 2013) where he held the title of Chief Executive Officer, and also the founder of Halo Neuro, Inc. (founded in 2013) where he held the title of Chief Executive Officer & Director until 2020.
Currently, he is the Managing Director at Palo Santo Inc and the Chief Business Officer at RubrYc Therapeutics, Inc. where he started in 2021.
Previously, he was the Chief Executive Officer & Director at Herophilus, Inc. from 2020 to 2021, and a Board of Advisor at The Brigham & Women's Hospital, Inc. from 2018 to 2020.
Dr. Chao has an undergraduate degree from the University of California, Berkeley and a graduate degree from Stanford University School of Medicine.
Daniel S. Chao active positions
| Companies | Position | Start |
|---|---|---|
RubrYc Therapeutics, Inc.
 RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Corporate Officer/Principal | 2021-06-30 |
Palo Santo Inc
 Palo Santo Inc Investment ManagersFinance Palo Santo Inc (Palo Santo) is a venture capital firm founded in 2005 by Timothy J Schlidt and Daniel L. Goldberg. The firm is headquartered in New York. | Private Equity Investor | - |
Former positions of Daniel S. Chao
| Companies | Position | End |
|---|---|---|
Herophilus, Inc.
 Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Chief Executive Officer | 2021-04-30 |
Halo Neuro, Inc.
 Halo Neuro, Inc. Packaged SoftwareTechnology Services Halo Neuro, Inc. develops neuroscience based technology. It offers its products under the categories of fitness, sports, gaming, health, biotech, wearables and other consumer technology. The company was founded by Brett Wingeier, Amol R. Sarva, Lee M. von Kraus and Daniel S. Chao in 2013 and is headquartered in San Francisco, CA. | Founder | 2020-10-31 |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Director/Board Member | 2020-10-31 |
Training of Daniel S. Chao
| Stanford University School of Medicine | Graduate Degree |
| University of California, Berkeley | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
RubrYc Therapeutics, Inc.
RubrYc Therapeutics, Inc. BiotechnologyHealth Technology RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA. | Health Technology |
Herophilus, Inc.
Herophilus, Inc. Packaged SoftwareTechnology Services Herophilus, Inc. operates as neurotherapeutics company. It employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. The firm combines cerebral organoid science, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. The company was founded by Frederic J. Kerrest, Sean Escola and Saul Kato and is headquartered in San Francisco, CA. | Technology Services |
Halo Neuro, Inc.
Halo Neuro, Inc. Packaged SoftwareTechnology Services Halo Neuro, Inc. develops neuroscience based technology. It offers its products under the categories of fitness, sports, gaming, health, biotech, wearables and other consumer technology. The company was founded by Brett Wingeier, Amol R. Sarva, Lee M. von Kraus and Daniel S. Chao in 2013 and is headquartered in San Francisco, CA. | Technology Services |
The Brigham & Women's Hospital, Inc.
The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Health Services |
Palo Santo Inc
Palo Santo Inc Investment ManagersFinance Palo Santo Inc (Palo Santo) is a venture capital firm founded in 2005 by Timothy J Schlidt and Daniel L. Goldberg. The firm is headquartered in New York. | Finance |
- Stock Market
- Insiders
- Daniel S. Chao
